Benesch Welcomes Partner Zach Dann to Expanding PE Practice in New York

Benesch is pleased to welcome Zach Dann to its rapidly growing Private Equity Practice Group as a partner in the firm’s expanding New York office. A seasoned BigLaw attorney and former hedge fund general counsel, Zach brings a multifaceted perspective at the intersection of law and business. He combines deep transactional experience and commercially focused guidance to help clients navigate complex deals, positioning them for sustained growth and competitive success.

“I know firsthand that Zach has outstanding M&A deal experience from our time working together at Kirkland & Ellis,” said Doug DiMedio, Co-Chair of Benesch’s Private Equity Practice Group. “His in-house experience gives him a unique understanding of the client experience that most deal attorneys cannot fully appreciate, allowing him to provide service that is perfectly aligned with client needs and expectations. We’re excited for him to bring this dynamic combination to our robust and growing middle market private equity practice, where he will be a perfect complement and invaluable asset to our team and clients.” 

“I’m thrilled to be joining Benesch and was particularly drawn by the firm’s remarkable growth rate and the opportunity to contribute to its growing private equity practice. I’m especially looking forward to working again with many of my former Kirkland colleagues who have joined the firm over the past few years,” said Dann.

With a practice firmly rooted in corporate transactions and matters, Zach advises on complex multimillion-dollar and billion-dollar M&A and private equity transactions, including mergers, acquisitions, divestitures, joint ventures, equity financings, PIPE transactions, equity-linked structures and general corporate governance. His clients include large and middle-market private equity funds and their portfolio companies, as well as publicly traded corporations, all of which cover a wide range of industries. Over the course of his career, he has advised on several landmark transactions, including Bristol-Myers Squibb’s $90 billion acquisition of Celgene Corporation—one of the largest pharmaceutical mergers in history.

Prior to joining Benesch, Zach served as general counsel at New Circle Capital, a special situations hedge fund. Earlier in his career, he was an associate at Kirkland & Ellis LLP. Zach earned his J.D., cum laude, from Fordham University School of Law and his B.A. from the University of Pennsylvania.